Argus Upgrades Silk Road Medical (NASDAQ:SILK) to Buy
Silk Road Medical (NASDAQ:SILK – Get Free Report) was upgraded by research analysts at Argus from a “hold” rating to a “buy” rating in a research note issued on Thursday, Marketbeat Ratings reports. The firm presently has a $24.00 price target on the stock. Argus’ target price would suggest a potential upside of 46.34% from […]
More Stories
Princess Private Equity (LON:PEY) Shares Pass Above 50 Day Moving Average – Time to Sell?
Shares of Princess Private Equity (LON:PEY – Get Free Report) passed above its fifty day moving average during trading on...
ATCO (OTCMKTS:ACLLF) Share Price Crosses Below 50-Day Moving Average – What’s Next?
ATCO Ltd. (OTCMKTS:ACLLF – Get Free Report)’s share price passed below its 50 day moving average during trading on Tuesday...
Klondike Silver (CVE:KS) Shares Down 50% – What’s Next?
Klondike Silver Corp. (CVE:KS – Get Free Report) traded down 50% during trading on Tuesday . The stock traded as...
Oceanic Iron Ore (CVE:FEO) Shares Up 66.7% – Time to Buy?
Shares of Oceanic Iron Ore Corp. (CVE:FEO – Get Free Report) rose 66.7% on Thursday . The company traded as...
Air T (NASDAQ:AIRT) Shares Cross Below 200 Day Moving Average – Should You Sell?
Air T, Inc. (NASDAQ:AIRT – Get Free Report)’s stock price passed below its 200-day moving average during trading on Tuesday...
RedHill Biopharma (NASDAQ:RDHL) Share Price Passes Below 200-Day Moving Average – Time to Sell?
RedHill Biopharma Ltd. (NASDAQ:RDHL – Get Free Report) passed below its 200-day moving average during trading on Tuesday . The...